Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Dr Jane Elliott AM & Prof Rod Baber AM
Non-Hormonal Options for Menopausal Symptoms
Prof Rukshen Weerasooriya
Holter Monitoring in GP – Cases and Practical Tips
Dr Rupert Hinds
Management of Constipation in Children
A/Prof Greg Katsoulotos
Inhaler Devices – Common User Errors
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
